John W. Baddley, United States

Johns Hopkins University School of Medicine

John W. Baddley, MD, MSPH, is a Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. He serves as Director, Transplant and Oncology Infectious Diseases and as Associate Director of the Clinical Trials Core in the Transplant Research Center. Dr. Baddley serves as President of the Transplantation Society’s Transplant Infectious Diseases Section

Stephanie Pouch, United States

Associate Professor of Medicine
Director, Transplant Infectious Diseases
Emory University School of Medicine
Atlanta, Georgia, United States

Stephanie Pouch, MD, MS, FAST, FIDSA is an Associate Professor of Medicine and transplant infectious diseases physician at Emory University School of Medicine. Her clinical and research interests include donor evaluation and donor-derived infections, as well as multidrug-resistant bacterial infections. She is active within the transplant community, serving as a Councilor in the TID Section of TTS, Co-Chair of the American Society of Transplantation Infectious Disease Community of Practice’s Donor Evaluation Working Group, and Chair of the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee.

Ricardo La Hoz, United States

Director, Transplant Infectious Diseases
Program Director, Transplant Infectious Diseases Fellowship
Medical Director, Transplant Services Center,
Associate Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas, United States

Ricardo M. La Hoz, MD, FACP, FAST, FIDSA, is an Associate Professor at UT Southwestern Medical Center in the Division of Infectious Diseases and Geographic Medicine. He serves as the Director of Transplant Infectious Diseases, Transplant Infectious Diseases Program Director, and Medical Director of Transplant Services Center. He chaired the OPTN Ad Hoc Disease Transmission Advisory Committee from 2020-2022 and, since 2024 Chairs the American Society of Transplantation Infectious Diseases Community of Practice.

Camille N. Kotton, United States

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital 
Associate Professor, Harvard Medical School

Camille Nelson Kotton, MD, FIDSA, FAST, is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and associate professor of medicine at Harvard Medical School in Boston, MA.

Dr Kotton’s clinical interests include cytomegalovirus, vaccines, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. She was a member of the CDC Advisory Committee on Immunization Practices (ACIP) 2020-2024. Dr Kotton has served as the chair of The Infectious Disease Community of Practice of The American Society of Transplantation. She has also served as the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her work include the development of 4 versions of the international guidelines on CMV management after solid organ transplant and updated international guidelines on BK management, all published in Transplantation. She is the first transplant infectious disease specialist to be on the executive committee of The Transplantation Society.

Lara Danziger-Isakov, United States

Professor of Pediatrics
Interim Division Director
Director, Immunocompromised Host Infectious Disease
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio, United States

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Professor of Pediatrics at the University of Cincinnati. She is Director of Immunocompromised Host Infectious Disease and Interim Division Director. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on solid organ and stem cell transplantation. She is funded through the National Institutes of Health to evaluate influenza vaccination strategies in pediatric solid organ transplantation, and she co-leads a national collaborative to address live viral vaccination including MMR in pediatric solid organ transplant recipients.